A study recently disclosed by the American Epilepsy Society (AES) has found a cannabis by-product to be effective in combating brain disease, with the substance exhibiting acute effectivity in treating the condition at intervals in children. The study – titled “Efficacy and Safety of Epidiolex (Cannabidiol) in children and Young Adults With Treatment-Resistant Epilepsy” – was disclosed at the AES’s 70th annual meeting last month.
The study found that Cannabidiol (CBD) was effective in reducing the frequency and severity of seizures in children and adults. It began in Philadelphia in 2014 with children from epilepsy treatment centers nationwide, specifically patients who received the treatment were found to have exhibited a median reduction in seizures of 45.1 percent. The study was unequivocal in its findings.
These results from an uncontrolled study support the animal studies and previous reports showing that CBD is also a promising treatment for treatment-resistant epilepsies and it’s usually well-tolerated in doses up to 25mg/kg/day per Dr. Orrin Devinsky, a lead author of the study and neurologist at the New York University Langone medical center, the findings were extremely promising. Within the resultant periods nine percent of all patients and thirteen percent of those with Dravet Syndrome brain disorder were seizure-free.
Many haven’t been seizure-free before.The leaders of the study are outspoken concerning its findings, stressing that it’s amongst the larger body of analysis to counsel that cannabis and its derivatives are effective in combating Epileptic Seizures. Elizabeth A. Thiele, M.D., Ph.D. – a lead author of the study – said in an AES announcement that the study’s findings might offer hope to various epilepsy patients.
For many children with the treatment-resistant Dravet syndrome, Lennox-Gastaut syndrome and different epilepsies, CBD seems to be a good – generally extraordinarily effective – treatment that’s safe and well-tolerated overall. Thiele was fast to denote, however, that patients and observers ought to work to manage their expectations, it’s not a solution, however, there are children who receive relief in this more than they have from different treatments.
Despite the promise shown by the effectivity of cannabis in treating brain disease, physicians have nonetheless cautioned against patients – and particularly patients’ parents – attempting to acquire and prescribe the substance on their own. This development is difficult, says Nicole Hansen, the mother of a seven-year-old boy with brain disease, since an absence of doctor input could usually cause inexact dosages for the patient. Some folks, however, don’t have any choice: several of these with children whose epileptic conditions are found to be treatable with CBD Oil are being forced to get the drugs through back channels.
Share this Post